Leveraging the Experiences of IVERIC Bio to Optimize the Dry AMD Therapeutic Approval Process
Time: 8:30 am
day: Conference Day 1
Details:
- Defining and building RA Strategy and Metrics of success
- Collaborating effectively with the FDA to streamline the approval process
- Sharing key insights to reduce future barriers to approval
